Business Standard

Bharat Immunological & Biological Corporation reports standalone net loss of Rs 1.98 crore in the June 2017 quarter

Image

Capital Market

Sales decline 87.95% to Rs 3.35 crore

Net Loss of Bharat Immunological & Biological Corporation reported to Rs 1.98 crore in the quarter ended June 2017 as against net loss of Rs 0.38 crore during the previous quarter ended June 2016. Sales declined 87.95% to Rs 3.35 crore in the quarter ended June 2017 as against Rs 27.79 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales3.3527.79 -88 OPM %-61.19-1.80 -PBDT-1.78-0.36 -394 PBT-1.92-0.53 -262 NP-1.98-0.38 -421

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 25 2017 | 4:29 PM IST

Explore News